Abstract

Increasingly, as globalisation widens the democratic deficit, the important decisions made with respect to biotech products by the large multinational biotechnology companies are having a big impact at the national, regional and international level. Until recently, because of strong oppositions from civil society in Europe, a number of EU governments have found it increasingly difficult to pursue a policy of fostering food biotechnology. However, in 2001 and 2002, EU Parliament approved very important legislations on biotechnology and GMO products to foster these products in European zone after multinational biotech companies successfully conducted their lobbying activities. In this paper, I examine the EU regulatory process on GMOs and its fundamental institutions, the European Parliament and European Commission in relation to European Biotech companies' powerful lobby group, EuropaBio